In Special Issue 5 of 2015 (1) I. van Moort, (2) R. A. A. Mathôt and (1) M. H. Cnossen (1Department of Pediatric Hematology, Sophia Children’s Hospital, Erasmus University Medical Center, The Netherlands. 2 Department of Clinical Pharmacy, Academic Medical Center, The Netherlands) described the patient-tailored therapy in haemophilia A: Towards pharmacokinetically guided dosing of factor VIII replacement therapy.
